 |
|
|
| |
Switching from Ritonavir (RTV) to Cobicistat (COBI) in HIV Patients with Renal Impairment Who Are Virologically Suppressed on a Protease Inhibitor based Regimen
|
| |
| |
Reported by Jules Levin
54th Interscience Conference on Antimicrobial Agents and Chemotherapy
September 5-9, 2014
Washingtion DC, USA
C McDonald1, C Martorell2, M Ramgopal3, F Laplante4, C Beraud5, C
Tran-Muchowski5, Y Liu5, MS Rhee5, J Szwarcberg5
1Tarrant County Infectious Disease Associates, Fortworth, TX, US; 2The Research Institute, Springfiled, MA, US; 3Midway Immunology and Research Center, Fort Pierce, FL, US; 4Clinique Medicale du Quartier Latin, Montreal, Canada; 5Gilead Sciences, Foster City, CA, US
|
| |
|
|
|
|
|
